NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,190,708 | -13.7% | 23,410 | -6.9% | 0.05% | -7.7% |
| Q2 2023 | $2,538,088 | +1.1% | 25,152 | -7.9% | 0.05% | -1.9% |
| Q1 2023 | $2,511,324 | -14.2% | 27,297 | -15.4% | 0.05% | -1.9% |
| Q4 2022 | $2,927,170 | +22.7% | 32,266 | +2.8% | 0.05% | +12.5% |
| Q3 2022 | $2,385,000 | -10.9% | 31,376 | -0.9% | 0.05% | -5.9% |
| Q2 2022 | $2,677,000 | -14.2% | 31,673 | -10.9% | 0.05% | 0.0% |
| Q1 2022 | $3,119,000 | -13.3% | 35,544 | -13.6% | 0.05% | -8.9% |
| Q4 2021 | $3,597,000 | +32.8% | 41,121 | +24.2% | 0.06% | +19.1% |
| Q3 2021 | $2,708,000 | +14.9% | 33,112 | +20.1% | 0.05% | +9.3% |
| Q1 2021 | $2,357,000 | -23.7% | 27,575 | -15.7% | 0.04% | -27.1% |
| Q4 2020 | $3,088,000 | -4.9% | 32,706 | -12.4% | 0.06% | -16.9% |
| Q3 2020 | $3,248,000 | -19.5% | 37,353 | -19.1% | 0.07% | -25.3% |
| Q2 2020 | $4,034,000 | +26.9% | 46,186 | +19.8% | 0.10% | +3.3% |
| Q1 2020 | $3,179,000 | -16.3% | 38,560 | -3.8% | 0.09% | +7.0% |
| Q4 2019 | $3,796,000 | +54.0% | 40,092 | +41.3% | 0.09% | +45.8% |
| Q3 2019 | $2,465,000 | -1.3% | 28,364 | +3.6% | 0.06% | -1.7% |
| Q2 2019 | $2,498,000 | -20.6% | 27,366 | -16.4% | 0.06% | -20.0% |
| Q1 2019 | $3,148,000 | +14.6% | 32,745 | +2.3% | 0.08% | -5.1% |
| Q4 2018 | $2,746,000 | -6.3% | 32,003 | -5.9% | 0.08% | +6.8% |
| Q3 2018 | $2,931,000 | +18.4% | 34,014 | +3.8% | 0.07% | +10.4% |
| Q2 2018 | $2,475,000 | +19.6% | 32,760 | +28.0% | 0.07% | +13.6% |
| Q1 2018 | $2,070,000 | +2.7% | 25,601 | +6.7% | 0.06% | +5.4% |
| Q4 2017 | $2,015,000 | -5.7% | 23,997 | -3.6% | 0.06% | -9.7% |
| Q3 2017 | $2,137,000 | +3.5% | 24,901 | +0.7% | 0.06% | -4.6% |
| Q2 2017 | $2,065,000 | -35.0% | 24,729 | -42.2% | 0.06% | -34.3% |
| Q1 2017 | $3,176,000 | +23.7% | 42,774 | +21.4% | 0.10% | +17.9% |
| Q4 2016 | $2,567,000 | +26.4% | 35,244 | +37.1% | 0.08% | +25.4% |
| Q3 2016 | $2,031,000 | -23.5% | 25,712 | -20.1% | 0.07% | -28.7% |
| Q2 2016 | $2,654,000 | +12.3% | 32,164 | -1.4% | 0.09% | +10.6% |
| Q1 2016 | $2,363,000 | +3.1% | 32,614 | +22.5% | 0.08% | +2.4% |
| Q4 2015 | $2,291,000 | -3.5% | 26,626 | +3.1% | 0.08% | -6.7% |
| Q3 2015 | $2,373,000 | -6.2% | 25,818 | +0.3% | 0.09% | +3.5% |
| Q2 2015 | $2,531,000 | +16.6% | 25,732 | +16.9% | 0.09% | +17.8% |
| Q1 2015 | $2,171,000 | -48.1% | 22,018 | -51.2% | 0.07% | -49.3% |
| Q4 2014 | $4,184,000 | +115.2% | 45,151 | +118.6% | 0.14% | +121.5% |
| Q3 2014 | $1,944,000 | +5.4% | 20,654 | +1.4% | 0.06% | +10.2% |
| Q2 2014 | $1,845,000 | +8.5% | 20,377 | +1.9% | 0.06% | +5.4% |
| Q1 2014 | $1,700,000 | +8.3% | 19,991 | +2.4% | 0.06% | +5.7% |
| Q4 2013 | $1,570,000 | -0.4% | 19,529 | -4.9% | 0.05% | -7.0% |
| Q3 2013 | $1,576,000 | -11.9% | 20,543 | -18.7% | 0.06% | -16.2% |
| Q2 2013 | $1,788,000 | – | 25,278 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |